Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ER Niacin/Laropiprant in Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT00479388Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of laropiprant + niacin in hypercholesterolemia, mixed dyslipidemia, sponsored by Merck & Co.. Started Jul 2007; status: completed.
02
Drugs
laropiprant + niacin
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT00479388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479388.